To date, several highlights have been reported: mutations in TP53 ranging from approximately 5%–28% in most series, variable deletion of the RB1 locus, and more recently, a novel study reporting a 10% frequency of mutation of PIK3CA in 60 MCC samples [5,39,56]. This evidence concerns the gene TP53 and Merkel cell skin cancer.